Travis Biechele

Chief Scientific Officer Shasqi Inc.

Seminars

Tuesday 13th October 2026
Utilizing Theranostics & Quantitative Systems Pharmacology to Enhance Translatability of Pre-Targeted ADC Therapies
3:00 pm
  • Discussing the importance of QSP modeling to determine translation of ADC dosing paradigms between animal and human studies
  • Leveraging theranostics to better determine efficacy and safety of ADCs in the clinic
  • Using PDX models to explore relationships between antigen expression level and efficacy
_Travis Biechele - Speaker at 17th World ADC San Diego Summit